Endurant Capital Management LP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2019$735,000
+21.1%
271,240
+323.4%
0.29%
+7.8%
Q3 2018$607,000
-8.6%
64,065
-6.2%
0.27%
-6.2%
Q2 2018$664,000
-50.9%
68,265
-67.6%
0.29%
-30.3%
Q4 2017$1,351,000
+124.8%
210,800
+168.5%
0.41%
+126.9%
Q3 2017$601,000
-19.1%
78,500
-24.9%
0.18%
-13.3%
Q2 2017$743,000104,5000.21%
Other shareholders
IMMUNOGEN INC shareholders Q1 2018
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders